More recently, an inhibitor of the histone lysine acetyltransferases (KATs) KAT6A and KAT6B, has been shown to induce INK4/ARF‐dependent senescence in cancer cell lines, explaining their ability to hinder lymphoma progression [193]. This evidence concerns the gene CDKN2A and cancer.